Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,901 | 246 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $629.04 | 39 | $0 (2024) |
| ABBVIE INC. | $596.54 | 39 | $0 (2022) |
| Amgen Inc. | $523.84 | 21 | $0 (2024) |
| LEO Pharma Inc. | $506.23 | 22 | $0 (2024) |
| GENZYME CORPORATION | $475.04 | 13 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $330.74 | 26 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $284.52 | 17 | $0 (2023) |
| Janssen Biotech, Inc. | $264.63 | 11 | $0 (2024) |
| UCB, Inc. | $211.69 | 11 | $0 (2021) |
| Dermavant Sciences, Inc. | $162.80 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $944.75 | 39 | PFIZER INC. ($225.10) |
| 2023 | $919.13 | 33 | GENZYME CORPORATION ($234.18) |
| 2022 | $647.68 | 28 | PFIZER INC. ($213.62) |
| 2021 | $2,390 | 146 | AbbVie Inc. ($522.53) |
All Payment Transactions
246 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Immunology | ||||||
| 10/02/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: DERMATOLOGY | ||||||
| 09/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $125.17 | General |
| Category: Dermatology | ||||||
| 09/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: DERMATOLOGY | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: Dermatology | ||||||
| 08/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Immunology | ||||||
| 07/02/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: Dermatology | ||||||
| 06/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Inflammation | ||||||
| 06/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: DERMATOLOGY | ||||||
| 05/23/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: DERMATOLOGY | ||||||
| 05/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $36.44 | General |
| Category: Immunology | ||||||
| 04/30/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: DERMATOLOGY | ||||||
| 04/30/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: DERMATOLOGY | ||||||
| 04/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.92 | General |
| Category: Immunology | ||||||
| 04/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 946 | 1,763 | $193,556 | $57,260 |
| 2022 | 9 | 657 | 1,153 | $138,639 | $41,623 |
| 2021 | 8 | 522 | 1,051 | $80,277 | $37,701 |
| 2020 | 7 | 438 | 985 | $60,490 | $31,272 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 254 | 352 | $60,711 | $18,784 | 30.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 127 | 174 | $38,516 | $11,794 | 30.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 167 | 246 | $32,000 | $7,998 | 25.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 65 | 71 | $14,062 | $4,080 | 29.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 86 | 100 | $10,840 | $3,460 | 31.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $11,558 | $3,187 | 27.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 117 | 675 | $8,792 | $2,982 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 43 | $10,497 | $2,955 | 28.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 15 | 21 | $2,058 | $741.35 | 36.0% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 12 | 13 | $2,577 | $678.43 | 26.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $1,944 | $600.12 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 175 | 236 | $41,583 | $12,476 | 30.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 105 | 149 | $33,431 | $11,074 | 33.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 120 | 162 | $21,289 | $5,543 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 66 | 66 | $14,336 | $3,843 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 29 | $7,201 | $2,189 | 30.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 30 | 33 | $6,720 | $1,932 | 28.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 84 | 424 | $5,588 | $1,883 | 33.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 40 | 42 | $4,611 | $1,510 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,881 | $1,172 | 30.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 191 | 292 | $30,862 | $16,445 | 53.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 94 | 143 | $13,577 | $5,545 | 40.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 49 | 59 | $9,735 | $4,357 | 44.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 43 | 43 | $6,560 | $3,246 | 49.5% |
| 17111 | Destruction of 15 or more non-cancerous skin growths | Office | 2021 | 15 | 37 | $6,562 | $3,134 | 47.8% |
About Natalie Driscoll, NP
Natalie Driscoll, NP is a Nurse Practitioner healthcare provider based in Middletown, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2014. The National Provider Identifier (NPI) number assigned to this provider is 1982014502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Natalie Driscoll, NP has received a total of $4,901 in payments from pharmaceutical and medical device companies, with $944.75 received in 2024. These payments were reported across 246 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,901).
As a Medicare-enrolled provider, Driscoll has provided services to 2,563 Medicare beneficiaries, totaling 4,952 services with total Medicare billing of $167,855. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Middletown, RI
- Active Since 05/05/2014
- Last Updated 10/04/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1982014502
Products in Payments
- DUPIXENT (Biological) $643.43
- Otezla (Drug) $490.35
- EUCRISA (Drug) $331.52
- ENSTILAR (Drug) $283.04
- SKYRIZI (Biological) $270.26
- COSENTYX (Biological) $249.08
- HUMIRA (Biological) $243.02
- ADBRY (Biological) $223.19
- ARAZLO (Drug) $215.08
- Cimzia (Drug) $211.69
- TREMFYA (Drug) $210.14
- CIBINQO (Drug) $204.40
- VTAMA (Drug) $162.80
- Zoryve (Drug) $156.03
- TALTZ (Drug) $137.29
- DUOBRII (Drug) $115.66
- LITFULO (Drug) $93.12
- Ilumya (Biological) $77.22
- OPZELURA (Drug) $64.76
- REMICADE (Biological) $54.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Middletown
Chandni Patel
Nurse Practitioner — Payments: $87,174
Ms. Kimberly Boldon, Np-C, NP-C
Nurse Practitioner — Payments: $14,710
Mr. Joshua Alderman, Aprn, APRN
Nurse Practitioner — Payments: $9,629
Mrs. Dana O'sullivan, Aprn, APRN
Nurse Practitioner — Payments: $4,096
Kimberly Hudson, Aprn, APRN
Nurse Practitioner — Payments: $2,791
Katie Lee, Np, NP
Nurse Practitioner — Payments: $2,212